Mozambique Country Profile: Taj Pharma – Generic Medicine Company Exporting Medicines to Mozambique

Mozambique is an important Southeast African pharmaceutical market with a growing population, substantial healthcare needs, and a regulatory system that is becoming increasingly sophisticated. For pharmaceutical importers, distributors, hospitals, procurement organizations, and other authorized buyers, reliable international manufacturers are important for maintaining continuity of medicine supply.

Taj Pharma provides pharmaceutical manufacturing and export services from India and can work with qualified international buyers interested in supplying medicines to Mozambique, subject to Mozambican regulatory authorization, product registration, import licensing, and applicable quality requirements.

The information below combines current country and regulatory data from authoritative sources, including the World Bank, WHO, and Mozambique’s national medicines regulator, ANARME.

Mozambique Country Profile – Key Facts

Country InformationAccurate Current Data
Official NameRepublic of Mozambique
CapitalMaputo
RegionSoutheast Africa
Population35,631,653 (2025 World Bank data)
AreaApproximately 799,380 km² according to World Bank WDI data
Official LanguagePortuguese
CurrencyMozambican Metical (MZN)
CoastlineApproximately 2,700 km on the Indian Ocean
Regulatory Authority for MedicinesANARME, IP
Current Regulatory MilestoneWHO Maturity Level 3 achieved in 2026
Main Commercial CentreMaputo
Geographical RegionSouthern Africa
Major NeighboursTanzania, Malawi, Zambia, Zimbabwe, South Africa and Eswatini
Life Expectancy64 years (2024 World Bank data)
Internet Usage21% of population (2024)
Electricity Access36.9% of population (2024)
Inflation4.4% (2025 World Bank data)
Real GDP Growth Projection2.1% in 2026; 3.5% in 2027, according to African Development Bank

The World Bank reports Mozambique’s population at 35.63 million in 2025, rather than the older 33.9-million figure often reproduced in country-profile articles. The World Bank also reports life expectancy of 64 years for 2024.

The World Bank describes Mozambique as having a coastline of approximately 2,700 km and notes that around two-thirds of the population lives in rural areas, which is highly relevant to healthcare distribution and pharmaceutical logistics.


Geography and Location of Mozambique

Mozambique is located on the southeastern side of Africa and faces the Indian Ocean. It borders Tanzania to the north, Malawi and Zambia to the northwest, Zimbabwe to the west, and South Africa and Eswatini to the south and southwest. Its long coastline provides important maritime connections for international trade.

The country’s geographic position also gives it strategic importance for regional commerce because its transport corridors connect coastal ports with several landlocked neighbouring countries.

For pharmaceutical businesses, geography matters because medicine supply does not end at the port. Products may need to move from international manufacturing facilities through ports and inland transportation networks before reaching wholesalers, distributors, healthcare institutions, pharmacies, and other authorized points of supply.


Population and Healthcare Market in Mozambique

Mozambique has a young and rapidly growing population. According to the World Bank, the population reached 35,631,653 in 2025.

This demographic expansion creates long-term requirements for healthcare infrastructure, medical professionals, diagnostics, medicines, vaccines, and other healthcare products.

At the same time, healthcare access is affected by the country’s large rural population. The World Bank notes that approximately two-thirds of Mozambique’s population lives in rural areas and that many people continue to face limited access to basic services and economic opportunities.

This makes dependable pharmaceutical distribution particularly important.


Mozambique Pharmaceutical Market and Medicine Imports

Mozambique relies on international pharmaceutical supply for a significant proportion of medicines used within its healthcare system. International manufacturers and exporters can therefore play an important role in supporting medicine availability.

Indian pharmaceutical companies are potential suppliers for authorized Mozambican importers because India’s pharmaceutical manufacturing sector offers a broad range of generic medicines and pharmaceutical formulations.

For Taj Pharma, the Mozambique opportunity is based on establishing compliant relationships with authorized local importers, distributors, procurement organizations, and other eligible buyers.

The objective is not simply to export products but to create a supply chain based on:

  • Regulatory compliance
  • Product quality
  • Consistent manufacturing
  • Accurate documentation
  • Appropriate packaging
  • Reliable logistics
  • Supply continuity
  • Responsible distribution

ANARME – Mozambique’s National Medicines Regulatory Authority

The Autoridade Nacional Reguladora de Medicamentos (ANARME, IP) is Mozambique’s national medicines regulatory authority.

ANARME’s responsibilities include licensing entities involved in the manufacture, import, export, distribution, and retail sale of medicines, vaccines, biological products, and other health products. It also oversees market authorization, pharmacovigilance, inspections, and quality-related functions.

For pharmaceutical companies exporting to Mozambique, ANARME is therefore one of the most important regulatory institutions to understand.


Medicine Registration in Mozambique

A pharmaceutical product intended for commercialization in Mozambique generally needs the applicable Autorização de Introdução no Mercado (AIM) or another legally applicable authorization pathway.

ANARME describes AIM as the authorization allowing pharmaceutical products to be commercialized and distributed following evaluation of relevant aspects such as quality, safety, efficacy, or performance. The authority states that AIM can occur through registration, notification, or special/emergency importation depending on the applicable circumstances.

Therefore, an international pharmaceutical exporter should not assume that a medicine approved in India or another country can automatically be sold in Mozambique.

The Mozambican regulatory pathway must be assessed for each product.


Regulatory Documentation for Pharmaceutical Exporters

For a pharmaceutical product entering the Mozambican market, the exact documentation depends on the product, regulatory category, registration route, and current ANARME requirements.

Potential technical and regulatory documentation can include:

  • Pharmaceutical product dossier
  • Manufacturing licenses
  • GMP documentation
  • Certificate of Pharmaceutical Product where applicable
  • Certificate of Analysis
  • Stability data
  • Product specifications
  • Manufacturing information
  • Active ingredient information
  • Packaging information
  • Labeling and artwork
  • Product information
  • Safety and efficacy information
  • Regulatory certificates
  • Authorization documents
  • Import documentation

The actual submission requirements should always be confirmed against the current ANARME procedure and the product’s classification.


WHO Maturity Level 3 – Major 2026 Development

One of the most important recent developments in Mozambique’s pharmaceutical regulatory environment occurred in August 2026.

The World Health Organization announced that ANARME achieved Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines. WHO’s maturity framework assesses the effectiveness and capability of national regulatory authorities.

This is a significant development because it demonstrates continued strengthening of Mozambique’s medicines regulatory system.

For international pharmaceutical manufacturers, the development reinforces the importance of maintaining:

  • High-quality technical dossiers
  • Strong manufacturing systems
  • GMP compliance
  • Accurate product information
  • Effective quality assurance
  • Pharmacovigilance systems
  • Reliable regulatory communication

Mozambique’s SIRMED Pharmaceutical Registration System

ANARME is also advancing digitalization of medicine regulation.

The authority has announced the pilot phase of SIRMED, designed to modernize medicine registration and regulatory processes in Mozambique.

The move toward more digital regulatory processes can improve the organization and tracking of applications and may make pharmaceutical regulatory interactions more structured.

International manufacturers and local applicants should therefore keep their regulatory documentation organized and ready for electronic submission where applicable.


Portuguese Language and Pharmaceutical Documentation

Portuguese is Mozambique’s official language, making language compliance particularly important for pharmaceutical market entry.

Pharmaceutical companies preparing dossiers, labels, patient information, and other regulatory material should check ANARME’s current language requirements before submission.

A manufacturer should not simply copy labeling from another African or international market without verifying whether the proposed artwork and product information meet Mozambique’s requirements.

Importers and Pharmaceutical Distributors in Mozambique

A successful pharmaceutical export strategy requires cooperation between the foreign manufacturer and a properly authorized Mozambican business.

The local partner may be responsible for activities such as:

  • Regulatory representation
  • Import authorization
  • Customs procedures
  • Local warehousing
  • Distribution
  • Market access
  • Regulatory communication
  • Product traceability
  • Pharmacovigilance responsibilities

ANARME explicitly regulates entities involved in importing, exporting, distributing, manufacturing, and retailing medicines and other health products.

For this reason, Taj Pharma’s international supply should be conducted through qualified and appropriately authorized partners.


Generic Medicines from India to Mozambique

India is one of the world’s major pharmaceutical manufacturing centres, with extensive experience producing generic medicines for international markets.

For Mozambique, Indian pharmaceutical suppliers can potentially provide products across multiple therapeutic categories, depending on product registration and market demand.

Potential categories include:

  • Anti-infective medicines
  • Antimalarial products
  • Cardiovascular medicines
  • Diabetes and metabolic medicines
  • Pain-management products
  • Gastrointestinal medicines
  • Respiratory medicines
  • CNS medicines
  • Hospital medicines
  • Injectable formulations
  • Supportive-care medicines
  • Nutritional and deficiency-related products

Availability, registration status, and export eligibility must be checked for each individual product.


Why Taj Pharma for Mozambique?

Taj Pharma provides pharmaceutical manufacturing and international export services from India and positions itself as a supplier for overseas pharmaceutical markets.

For qualified Mozambican buyers, Taj Pharma can provide a potential sourcing relationship based on:

1. Indian Pharmaceutical Manufacturing

India’s established pharmaceutical industry provides access to manufacturing capabilities across numerous dosage forms and therapeutic areas.

2. Generic Medicine Portfolio

A broad generic medicine portfolio can help importers evaluate multiple pharmaceutical categories through an international manufacturing partner.

3. Regulatory Documentation

International pharmaceutical procurement requires detailed technical and quality documentation. Taj Pharma can coordinate applicable documentation for buyer and regulatory evaluation, subject to the product.

4. Export Coordination

International orders require coordination between manufacturer, importer, freight provider, customs authorities, and local distributor.

5. Quality-Focused Supply

Pharmaceutical products require controlled manufacturing and quality systems throughout the production process.

6. Long-Term Supply Relationships

A consistent manufacturer-importer relationship can help buyers plan procurement and maintain supply continuity.


WHO-GMP and Pharmaceutical Quality

Good Manufacturing Practice is fundamental to pharmaceutical production.

A manufacturer supplying international markets should maintain appropriate manufacturing controls covering:

  • Raw-material qualification
  • Manufacturing processes
  • Quality control
  • Laboratory testing
  • Batch release
  • Documentation
  • Packaging
  • Stability
  • Storage
  • Traceability

For Mozambique-bound products, the relevant GMP evidence and regulatory documents should be supplied according to the requirements of ANARME and the authorized local applicant.


Pharmacovigilance in Mozambique

Medicine safety does not end after a product is registered.

ANARME is responsible for pharmacovigilance, including the identification, detection, evaluation, understanding, and prevention of adverse effects and other medicine-related problems.

Therefore, pharmaceutical manufacturers and local partners need appropriate processes for handling safety information after products reach the market.

This is particularly important for long-term pharmaceutical supply relationships.


Antimicrobial Medicines and Responsible Distribution

Antimicrobial resistance is a major international public-health issue.

Mozambique has been strengthening coordination around antimicrobial resistance and medicine regulation. ANARME’s regulatory activities include oversight relevant to antimicrobial medicines.

Antibiotics should therefore be supplied and distributed through appropriate authorized channels, with attention to local prescription, regulatory, and pharmacovigilance requirements.


Pharmaceutical Logistics from India to Mozambique

International pharmaceutical logistics require careful planning.

A typical supply chain can involve:

Indian Manufacturer → Export Documentation → Freight/Shipping → Mozambican Importer → Customs → Licensed Warehouse → Distributor → Authorized Healthcare Channel

Important considerations include:

  • Product shelf life
  • Batch number
  • Expiry date
  • Packaging
  • Shipping conditions
  • Storage requirements
  • Import authorization
  • Customs documentation
  • Certificate of Analysis
  • Invoice and packing list
  • Transport conditions
  • Local distribution

Products requiring controlled temperature conditions require additional supply-chain planning.


Mozambique Economy and Pharmaceutical Demand

Mozambique’s economy has significant natural-resource potential but also faces substantial development challenges.

The African Development Bank’s June 2026 outlook projects real GDP growth of 2.1% in 2026 and 3.5% in 2027, with growth supported partly by a recovery in extractive activity and stronger private consumption.

The World Bank’s 2026 economic update emphasizes the importance of Mozambique’s growing and youthful population and the need for broader economic development beyond extractive industries.

Economic development, population growth, and healthcare investment can influence long-term demand for medicines and healthcare products, although pharmaceutical demand varies significantly by therapeutic area and procurement channel.


Healthcare Access and Pharmaceutical Distribution Challenges

Mozambique’s healthcare market faces geographic and infrastructure challenges.

With a large rural population and significant distances between population centres, distribution networks are particularly important. The World Bank identifies access to basic services as an ongoing challenge.

This makes the role of pharmaceutical importers and distributors especially important.

A successful supply partner should therefore consider not only the price of medicines but also:

availability + regulatory compliance + quality + logistics + storage + distribution + continuity of supply.


Taj Pharma – Pharmaceutical Exporter to Mozambique

Taj Pharma can work with authorized pharmaceutical businesses seeking to source medicines from India for the Mozambique market.

For every proposed product, the commercial and regulatory assessment should establish:

  • Whether the product is registered
  • Whether registration is required
  • Who will act as local applicant/importer
  • Whether the importer holds the required authorization
  • What technical documents are required
  • What labeling requirements apply
  • What packaging is permitted
  • What import authorization is necessary
  • What quality documentation is required
  • What logistics conditions are necessary

This product-by-product approach provides a more accurate basis for pharmaceutical market entry than treating every medicine as having identical requirements.


How to Import Generic Medicines from India to Mozambique

A practical market-entry process can be structured as follows:

Step 1 – Select Products: Identify medicines with legitimate market demand.

Step 2 – Check Regulatory Status: Determine the applicable ANARME registration or authorization pathway.

Step 3 – Select a Licensed Local Partner: Work with an appropriately authorized Mozambican importer/distributor.

Step 4 – Prepare Documentation: Assemble the technical, quality, manufacturing, commercial, and regulatory documentation required for the product.

Step 5 – Regulatory Submission: Submit the applicable application through the appropriate ANARME process.

Step 6 – Product Approval: Complete the relevant authorization process before commercial distribution where required.

Step 7 – Import Authorization: Complete applicable import procedures.

Step 8 – Shipment: Coordinate compliant pharmaceutical transportation from India to Mozambique.

Step 9 – Local Distribution: Move products through authorized storage and distribution channels.

Step 10 – Pharmacovigilance: Maintain appropriate post-market safety monitoring.


Mozambique Pharmaceutical Market: Key Opportunities

Several factors make Mozambique relevant for international pharmaceutical suppliers:

  • Population of more than 35.6 million
  • Growing healthcare requirements
  • Large rural population
  • Need for dependable medicine distribution
  • Developing regulatory infrastructure
  • Increasing digitalization of pharmaceutical regulation
  • Strengthening national regulatory authority
  • Strategic Indian Ocean location
  • Opportunities for international pharmaceutical partnerships
  • Potential demand across multiple therapeutic categories

The country’s pharmaceutical opportunity should nevertheless be approached through regulatory compliance and sustainable supply, rather than relying solely on market size.


Mozambique is an important and developing pharmaceutical market in Southeast Africa. Its 35.6-million-plus population, healthcare requirements, large rural communities, strategic location, and evolving medicines regulatory system create opportunities for qualified international pharmaceutical suppliers.

The country’s regulatory environment is also strengthening. ANARME achieved WHO Maturity Level 3 in 2026, representing a major milestone for Mozambique’s medicines regulatory system.

For pharmaceutical importers seeking products from India, Taj Pharma can serve as a potential generic medicine manufacturing and export partner, subject to product availability, buyer qualification, and all applicable Mozambican regulatory requirements.

The strongest pharmaceutical supply relationships are built around quality, regulatory compliance, documentation, reliable manufacturing, responsible distribution, and consistent supply.

10 Short One-Line FAQs

  1. Who regulates medicines in Mozambique? — ANARME, IP is Mozambique’s national medicines regulatory authority.
  2. What is Mozambique’s capital? — Maputo is the capital and largest city of Mozambique.
  3. What is Mozambique’s population? — The World Bank reports 35,631,653 people in 2025.
  4. Can India export generic medicines to Mozambique? — Yes, subject to applicable Mozambican registration, import, licensing, and regulatory requirements.
  5. Do medicines require authorization in Mozambique? — Applicable pharmaceutical products require the relevant ANARME authorization before commercialization.
  6. What language is used in Mozambique? — Portuguese is the country’s official language.
  7. What is ANARME’s current WHO maturity level? — WHO confirmed Maturity Level 3 in August 2026.
  8. Can Taj Pharma supply medicines to Mozambique? — Taj Pharma can work with qualified authorized buyers regarding available products and applicable export requirements.
  9. Does Mozambique have a medicine-registration system? — Yes, ANARME manages market authorization and is also developing SIRMED to modernize medicine registration.
  10. Why are Indian pharmaceutical manufacturers important to Mozambique? — Indian manufacturers can provide a broad range of generic medicines for international markets, subject to Mozambican approval and import requirements.